Rise above the curve.
Elevate your ETIQ.
ETIQ is a part of InnovateET, your dedicated channel for first-line endocrine therapy in HR+/HER2- mBC–coming soon!
Quiz library
ESR1 Mutation Monitoring to Detect Resistance Earlier and Extend First-Line Therapy
Test your knowledge of ESR1 mutation biology and the clinical implications of emerging endocrine resistance, with questions focused on the importance of proactive ctDNA-based mutation monitoring to extend first-line CDK4/6 inhibitor therapy in HR+/HER2- metastatic breast cancer.
Optimizing First-Line Outcomes
Mar 20, 2026
Understanding the Importance of Maximizing 1L ET Duration
Test your understanding of evidence-based approaches to maximizing first-line outcomes in HR+/HER2– metastatic breast cancer, with questions focused on endocrine therapy optimization, ESR1 mutation monitoring, and evolving treatment options.
Optimizing First-Line Outcomes
Dec 5, 2025
Stay tuned!
We’re adding new quizzes all the time! Bookmark this page so you don’t miss out, or sign up to get notified as soon as new ones are released.
How it works
Test your knowledge. Compare with peers. Lead with confidence.
